Showing results (4021-4030 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|March 7, 2012
The role of FLT3 kinase as an AML therapy targetMichał Beffinger, Anna SkwarskaCurrent Pharmaceutical Design|August 25, 2011
Ectopic fat storage, insulin resistance, and hypertensionAnna Maria Sironi, Rosa Sicari, Franco Folli, et al.Current Pharmaceutical Design|August 25, 2011
Cognitive decline as a consequence of essential hypertensionDavide Grassi, Livia Ferri, Paola Cheli, et al.Current Pharmaceutical Design|August 26, 2011
Anti-TNF treatment in rheumatoid arthritisJanina Geiler, Maya Buch, Michael F McDermottCurrent Pharmaceutical Design|August 26, 2011
B cell modulation strategies in autoimmunity: the SLE exampleM Manuela Rosado, Andrea Picchianti Diamanti, Federica Capolunghi, et al.Current Pharmaceutical Design|August 26, 2011
A pathogenetic approach to autoimmune skin disease therapy: psoriasis and biological drugs, unresolved issues, and future directionsEmira Ayroldi, Alessandra Bastianelli, Lorenza Cannarile, et al.Current Pharmaceutical Design|July 7, 2011
Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspectsNatalia Shiryaev, Regina Pikman, Eliezer Giladi, et al.Current Pharmaceutical Design|July 7, 2011
Peptoids: bio-inspired polymers as potential pharmaceuticalsMichelle T Dohm, Rinki Kapoor, Annelise E BarronCurrent Pharmaceutical Design|April 29, 2011
Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivoD Reglodi, P Kiss, A Lubics, et al.Current Pharmaceutical Design|April 29, 2011
Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a reviewSteven Edwards, George A Kenna, Robert M Swift, et al.Pageof 1,008